Cited by 332Sirtuins and Resveratrol in MedicineNatural Antidiabetic Agents StudiesBiochemical and Molecular Research

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38

Open access

Escande, Carlos, Nin, Veronica, Price, Nathan L., Capellini, Verena, Gomes, Ana P., Barbosa, Maria Thereza, O’Neil, Luke, White, Thomas A., Sinclair, David A., Chini, Eduardo N.·2013·Diabetes

DOI 10.2337/db12-1139PMC PMC3609577

Open this paper in CoChat — free account

Abstract

Metabolic syndrome is a growing health problem worldwide. It is therefore imperative to develop new strategies to treat this pathology. In the past years, the manipulation of NAD+ metabolism has emerged as a plausible strategy to ameliorate metabolic syndrome. In particular, an increase in cellular NAD+ levels has beneficial effects, likely because of the activation of sirtuins. Previously, we reported that CD38 is the primary NAD+ase in mammals. Moreover, CD38 knockout mice have higher NAD+ levels and are protected against obesity and metabolic syndrome. Here, we show that CD38 regulates global protein acetylation through changes in NAD+ levels and sirtuin activity. In addition, we characterize two CD38 inhibitors: quercetin and apigenin. We show that pharmacological inhibition of CD38 results in higher intracellular NAD+ levels and that treatment of cell cultures with apigenin decreases global acetylation as well as the acetylation of p53 and RelA-p65. Finally, apigenin administration to obese mice increases NAD+ levels, decreases global protein acetylation, and improves several aspects of glucose and lipid homeostasis. Our results show that CD38 is a novel pharmacological target to treat metabolic diseases via NAD+-dependent pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/db12-1139

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The metabolic syndrome
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
The metabolic syndrome
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,755
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.
Hedley, A. A., Ogden, C., Johnson, C. L., Carroll, M., Curtin, L. R., & Flegal, K. (2004) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.291.23.2847 · Cited by 4,670
Global nutrition transition and the pandemic of obesity in developing countries
Popkin, B. M., Adair, L. S., & Ng, S. W. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00456.x · Cited by 4,313
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Self-citation
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Self-citation
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,690

Flagged first, then by citations

Show all 48 references

1 of the 48 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 332

Systemic regulation of mammalian ageing and longevity by brain sirtuins
Satoh, A., & Imai, S. (2014) · Nature Communications · doi:10.1038/ncomms5211 · Cited by 63
Geroncogenesis: Metabolic Changes during Aging as a Driver of Tumorigenesis
Wu, L. E., Gomes, A. P., & Sinclair, D. A. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.005 · Cited by 62
Self-citation
Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan
Sharma, A., Chabloz, S., Lapides, R. A., Roider, E., & Ewald, C. Y. (2023) · Nutrients · doi:10.3390/nu15020445 · Cited by 64
Apigenin alleviates STZ-induced diabetic cardiomyopathy
Liu, H.-J., Fan, Y.-L., Liao, H.-H., Liu, Y., Chen, S., Ma, Z., Zhang, N., Yang, Z., Deng, W., & Tang, Q. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2913-9 · Cited by 60
NAD+ metabolism as a target for metabolic health: have we found the silver bullet?
Connell, N. J., Houtkooper, R. H., & Schrauwen, P. (2019) · Diabetologia · doi:10.1007/s00125-019-4831-3 · Cited by 60
APIGENIN CAUSES BIOCHEMICAL MODULATION, GLUT4 AND CD38 ALTERATIONS TO IMPROVE DIABETES AND TO PROTECT DAMAGES OF SOME VITAL ORGANS IN EXPERIMENTAL DIABETES
Hossain, C. M. (2014) · American Journal of Pharmacology and Toxicology · doi:10.3844/ajptsp.2014.39.52 · Cited by 59
Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity
Brady, P. N., Goel, A., & Johnson, M. A. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00038-18 · Cited by 58
NAD+ Metabolism in Aging and Cancer
Demarest, T. G., Babbar, M., Okur, M. N., Dan, X., Croteau, D. L., Fakouri, N. B., Mattson, M. P., & Bohr, V. A. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055905 · Cited by 58
Impact of NAD+ metabolism on ovarian aging
Liang, J., Huang, F., Song, Z., Tang, R., Zhang, P., & Chen, R. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00398-w · Cited by 59
Apigenin Alleviates Oxidative Stress-Induced Cellular Senescence via Modulation of the SIRT1-NAD+-CD38 Axis
Li, B. S., Zhu, R. Z., Lim, S.-H., Seo, J. H., & Choi, B.-M. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500592 · Cited by 54
Immunometabolism: signaling pathways, homeostasis, and therapeutic targets
Xu, R., He, X., Xu, J., Yu, G., & Wu, Y. (2024) · MedComm · doi:10.1002/mco2.789 · Cited by 64
The Inhibitory Effects of Purple Sweet Potato Color on Hepatic Inflammation Is Associated with Restoration of NAD+ Levels and Attenuation of NLRP3 Inflammasome Activation in High-Fat-Diet-Treated Mice
Wang, X., Zhang, Z.-F., Zheng, G., Wang, A., Sun, C., Qin, S., Zhuang, J., Lu, J. L., Ma, D., & Zheng, Y. (2017) · Molecules · doi:10.3390/molecules22081315 · Cited by 55
Dietary Apigenin promotes lipid catabolism, thermogenesis, and browning in adipose tissues of HFD-Fed mice
Sun, Y., & Qu, W. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110780 · Cited by 57
Clinical Evidence for Targeting NAD Therapeutically
Radenković, D., Reason, & Verdin, E. M. (2020) · Pharmaceuticals · doi:10.3390/ph13090247 · Cited by 55
Apigenin ameliorates hepatic lipid accumulation by activating the autophagy-mitochondria pathway
Hsu, M., Guo, B. C., Hu, P.-A., Chen, C. H., & Lee, T. (2021) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.3269 · Cited by 57
CD38 in the age of COVID-19: a medical perspective
Horenstein, A. L., Faini, A. C., & Malavasi, F. (2021) · Physiological Reviews · doi:10.1152/physrev.00046.2020 · Cited by 53
NAD+: A key metabolic regulator with great therapeutic potential
Sultani, G., Samsudeen, A., Osborne, B., & Turner, N. A. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12508 · Cited by 54
Current Status and Future Perspectives on Therapeutic Potential of Apigenin: Focus on Metabolic-Syndrome-Dependent Organ Dysfunction
Alam, W., Rocca, C., Khan, H. Z., Hussain, Y., Aschner, M., Bartolo, A. D., Amodio, N., Angelone, T., & Cheang, W. S. (2021) · Antioxidants · doi:10.3390/antiox10101643 · Cited by 56
CD38 inhibitor 78c increases mice lifespan and healthspan in a model of chronological aging
Peclat, T., Thompson, K. L., Warner, G. M., Chini, C. C. S., Tarragó, M. G., Mazdeh, D. Z., Zhang, C., Zavala‐Solorio, J., Kolumam, G. A., Wong, Y. L., et al. (2022) · Aging Cell · doi:10.1111/acel.13589 · Cited by 52
Self-citation
Renal mitochondrial oxidative stress is enhanced by the reduction of Sirt3 activity, in Zucker diabetic fatty rats
Ogura, Y., Kitada, M., Monno, I., Kanasaki, K., Watanabe, A., & Koya, D. (2018) · Redox Report · doi:10.1080/13510002.2018.1487174 · Cited by 52
Apigenin attenuates LPS-induced neurotoxicity and cognitive impairment in mice via promoting mitochondrial fusion/mitophagy: role of SIRT3/PINK1/Parkin pathway
Ahmedy, O. A., Abdelghany, T. M., El-Shamarka, M. E. A., Khattab, M. A., & El-Tanbouly, D. M. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06262-x · Cited by 52
The Central Role of the NAD+ Molecule in the Development of Aging and the Prevention of Chronic Age-Related Diseases: Strategies for NAD+ Modulation
Poljšak, B., Kovač, V., Špalj, S., & Milisav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032959 · Cited by 56
Roles of NAD+ in Acute and Chronic Kidney Diseases
Morevati, M., Fang, E. F., Mace, M. L., Kanbay, M., Gravesen, E., Nordholm, A., Egstrand, S., & Hornum, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010137 · Cited by 50
KL1333, a Novel NAD+ Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts
Seo, K.-S., Kim, J. H., Min, K.-N., Moon, J.-A., Roh, T. C., Lee, M., Lee, K., Min, J.-E., & Lee, Y. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00552 · Cited by 49
Phytochemicals, Biological Activities, Molecular Mechanisms, and Future Prospects of Plantago asiatica L.
Wen, S.-Y., Wei, B.-Y., Ma, J.-Q., Wang, L., & Chen, Y.-Y. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c07735 · Cited by 48
Apigenin reduces the excessive accumulation of lipids induced by palmitic acid via the AMPK signaling pathway in HepG2 cells
Lu, J., Meng, Z., Cheng, B., Liu, M., Tao, S., & Guan, S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7905 · Cited by 48
Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence
Abdelgawad, I. Y., Sadak, K. T., Lone, D. W., Dabour, M. S., Niedernhofer, L. J., & Zordoky, B. N. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107751 · Cited by 47
NAD+ and cardiovascular diseases
Lin, Q., Zuo, W., Liu, Y., Wu, K., & Liu, Q. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.01.012 · Cited by 49
Apigenin: a natural molecule at the intersection of sleep and aging
Kramer, D. J., & Johnson, A. A. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1359176 · Cited by 57
Targeting NAD+ degradation: The therapeutic potential of flavonoids for Alzheimer's disease and cognitive frailty
Ruan, Q., Ruan, J., Zhang, W., Qian, F., & Yu, Z. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.010 · Cited by 44
NAD+ Metabolism and Immune Regulation: New Approaches to Inflammatory Bowel Disease Therapies
Chen, C., Yan, W., Tao, M., & Fu, Y. (2023) · Antioxidants · doi:10.3390/antiox12061230 · Cited by 44
Anthracycline chemotherapy‐mediated vascular dysfunction as a model of accelerated vascular aging
Clayton, Z. S., Hutton, D. A., Mahoney, S. A., & Seals, D. R. (2021) · Aging and Cancer · doi:10.1002/aac2.12033 · Cited by 44
Recent Progress in Metabolic Signaling Pathways Regulating Aging and Life Span
Newgard, C. B., & Pessin, J. E. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu058 · Cited by 44
Retracted: The antiproliferative and apoptotic effects of apigenin on glioblastoma cells
Stump, T. A., Santee, B., Williams, L. P., Kunze, R., Heinze, C. E., Huseman, E. D., Gryka, R. J., Simpson, D. S., & Amos, S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12718 · Cited by 44
Retracted
Fruits: A Source of Polyphenols and Health Benefits
Calderón‐Oliver, M., & Ponce‐Alquicira, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811518-3.00007-7 · Cited by 46
Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility
Chiang, S.-H., Harrington, W. W., Luo, G., Milliken, N. O., Ulrich, J. C., Chen, J., Rajpal, D. K., Qian, Y., Carpenter, T. Y., Murray, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134927 · Cited by 40
A systems-approach to NAD+ restoration
Conlon, N. J., & Ford, D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114946 · Cited by 41
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting
Vaisitti, T., Audrito, V., Serra, S., Buonincontri, R., Sociali, G., Mannino, E., Pagnani, A., Zucchetto, A., Tissino, E., Vitale, C., et al. (2014) · Leukemia · doi:10.1038/leu.2014.207 · Cited by 40
Mono(ADP-ribosyl)ation Enzymes and NAD+ Metabolism: A Focus on Diseases and Therapeutic Perspectives
Poltronieri, P., Celetti, A., & Palazzo, L. (2021) · Cells · doi:10.3390/cells10010128 · Cited by 41
Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders
Leite, J. A., Ghirotto, B., Targhetta, V. P., de Lima, J., & Câmara, N. O. S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15570 · Cited by 42
Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides
Boslett, J. J., Helal, M., Chini, E. N., & Zweier, J. L. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.02.015 · Cited by 42
Self-citation
Nicotinamide riboside supplementation dysregulates redox and energy metabolism in rats: Implications for exercise performance
Kourtzidis, I. A., Dolopikou, C. F., Tsiftsis, A. N., Margaritelis, N. V., Theodorou, A. A., Zervos, I. A., Tsantarliotou, M. P., Veskoukis, A. S., Vrabas, I. S., Paschalis, V., et al. (2018) · Experimental Physiology · doi:10.1113/ep086964 · Cited by 39
Sirtuin Modulators in Cellular and Animal Models of Human Diseases
Hong, J. Y., & Lin, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.735044 · Cited by 40
Role of PGC-1α in the Mitochondrial NAD+ Pool in Metabolic Diseases
Koh, J., & Kim, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094558 · Cited by 39
Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
Poljšak, B., Kovač, V., & Milisav, I. (2022) · Antioxidants · doi:10.3390/antiox11091637 · Cited by 42
CD38 is methylated in prostate cancer and regulates extracellular NAD+
Mottahedeh, J., Haffner, M. C., Grogan, T., Hashimoto, T., Crowell, P. D., Beltran, H., Sboner, A., Bareja, R., Esopi, D., Isaacs, W. B., et al. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0186-3 · Cited by 41
CD 38 modulates respiratory syncytial virus‐driven proinflammatory processes in human monocyte‐derived dendritic cells
Schiavoni, I., Scagnolari, C., Horenstein, A. L., Leone, P., Pierangeli, A., Malavasi, F., Ausiello, C. M., & Fedele, G. (2017) · Immunology · doi:10.1111/imm.12873 · Cited by 36
CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets
Deshpande, D. A., Guedes, A. G. P., Lund, F. E., Subramanian, S., Walseth, T. F., & Kannan, M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.12.002 · Cited by 38
Reductive stress: The key pathway in metabolic disorders induced by overnutrition
Zhang, S., Wang, N., Gao, Z., Gao, Z., Wang, X., Xie, H., Wang, C.-Y., & Zhang, S. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.01.012 · Cited by 40
Flavonoids: A Nutraceutical and Its Role as Anti-inflammatory and Anticancer Agent
Saini, N., Gahlawat, S. K., & Lather, V. (2017) · Springer eBooks · doi:10.1007/978-981-10-4732-9_13 · Cited by 34
Interventions to slow cardiovascular aging: Dietary restriction, drugs and novel molecules
Heiß, C., Spyridopoulos, I., & Haendeler, J. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.06.015 · Cited by 36
Facile chemoenzymatic synthesis of a novel stable mimic of NAD +
Dai, Z., Zhang, X., Nasertorabi, F., Cheng, Q., Pei, H., Louie, S. G., Stevens, R. C., & Zhang, Y. (2018) · Chemical Science · doi:10.1039/c8sc03899f · Cited by 33
CD38: A Potential Therapeutic Target in Cardiovascular Disease
Zuo, W., Liu, N., Zeng, Y., Liu, Y., Li, B., Wu, K., Xiao, Y., & Liu, Q. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07007-8 · Cited by 36
A NOVEL NOX/PHOX-CD38-NAADP-TFEB AXIS IMPORTANT FOR MACROPHAGE ACTIVATION DURING BACTERIAL PHAGOCYTOSIS
Najibi, M., Honwad, H. H., Moreau, J. A., Becker, S. M., & Irazoqui, J. E. (2021) · Autophagy · doi:10.1080/15548627.2021.1911548 · Cited by 33
Effect of extracts and isolated compounds derived from Retama monosperma (L.) Boiss. on anti-aging gene expression in human keratinocytes and antioxidant activity
Zefzoufi, M., Fdil, R., Bouamama, H., Gadhi, C., Katakura, Y., Mouzdahir, A., & Sraïdi, K. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114451 · Cited by 36
Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids
Zhou, Y., Suo, W., Zhang, X., Yang, Y., Zhao, W., Li, H., & Ni, Q. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114025 · Cited by 36
Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases
Li, F., Wu, C., & Wang, G. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01072-3 · Cited by 37
Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis
Baruch, B. B., Blacher, E., Mantsur, E., Doron, H., Vaknine, H., Erez, N., & Stein, R. (2018) · Oncotarget · doi:10.18632/oncotarget.25737 · Cited by 30
Transcriptomics and proteomics analysis of system-level mechanisms in the liver of apigenin-treated fibrotic rats
Qiao, M., Yang, J., Zhu, Y., Zhao, Y., & Hu, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117475 · Cited by 32
Nutraceuticals and Their Contribution to Preventing Noncommunicable Diseases
Garza-Juárez, A. D. J., Pérez‐Carrillo, E., Arredondo‐Espinoza, E., Islas, J. F., Chao, D. F. B., & Escamilla-García, E. (2023) · Foods · doi:10.3390/foods12173262 · Cited by 35
Aryl hydrocarbon receptor (AHR), integrating energy metabolism and microbial or obesity-mediated inflammation
Bock, K. W. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114346 · Cited by 33
Apigenin and Quercetin Ameliorate Mitochondrial Alterations by Tunicamycin-Induced ER Stress in 3T3-L1 Adipocytes
Nisha, V. M., Anusree, S. S., Priyanka, A., & Raghu, K. G. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-1129-2 · Cited by 31
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity
Ugamraj, H. S., Dang, K. H., Ouisse, L., Buelow, B., Chini, E. N., Castello, G., Allison, J., Clarke, S., Davison, L. M., Buelow, R., et al. (2022) · mAbs · doi:10.1080/19420862.2022.2095949 · Cited by 31
Self-citation
Implications of NAD + boosters in translational medicine
Kang, B. E., Choi, J., Stein, S., & Ryu, D. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13334 · Cited by 32
Targeting CD38 to Suppress Osteoarthritis Development and Associated Pain After Joint Injury in Mice
Alabarse, P. V. G., Chen, L.-Y., Oliveira, P., Qin, H., & Liu‐Bryan, R. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42351 · Cited by 31
Host NAD+ metabolism and infections: therapeutic implications
Singhal, A., & Cheng, C. Y. (2018) · International Immunology · doi:10.1093/intimm/dxy068 · Cited by 31
Beneficial Flavonoid in Foods and Anti-obesity Effect
Liu, J., Cao, J., Li, Y., & Guo, F. (2021) · Food Reviews International · doi:10.1080/87559129.2021.1923730 · Cited by 29
NAD+ Homeostasis in Diabetic Kidney Disease
Xu, J., Kitada, M., & Koya, D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.703076 · Cited by 30
A pre-steady state and steady state kinetic analysis of the N-ribosyl hydrolase activity of hCD157
Preugschat, F., Carter, L. H., Boros, E. E., Porter, D. J. T., Stewart, E. L., & Shewchuk, L. M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.09.008 · Cited by 29
Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy
Wang, L., Liu, M., Zu, Y., Hong, Y., Wu, C., Zhang, R., Ma, W., Lu, H., Xi, S., Liu, Y., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114260 · Cited by 28
Dietary flavonoids prevent diabetes through epigenetic regulation: advance and challenge
Han, S., Luo, Y., Liu, B., Guo, T., Qin, D., & Luo, F. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2097637 · Cited by 28
NAD+ and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities
Abdellatif, M., Bugger, H., Kroemer, G., & Sedej, S. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.2.111 · Cited by 26
A novel nitroalkene vitamin E analogue inhibits the NLRP3 inflammasome and protects against inflammation and glucose intolerance triggered by obesity
Dapueto, R., Rodriguez‐Duarte, J., Galliussi, G., Kamaid, A., Bresque, M., Batthyány, C., López, G. V., & Escande, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101833 · Cited by 26
Self-citation
Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review
Khan, F. B., Singh, P., Jamous, Y. F., Ali, S. A., Abdullah, Shahab Uddin, M. S., Zia, Q., Jena, M. K., Khan, M., Owais, M., et al. (2022) · Cancers · doi:10.3390/cancers15010249 · Cited by 26
CK2 inhibition induced PDK4-AMPK axis regulates metabolic adaptation and survival responses in glioma
Dixit, D., Ahmad, F., Ghildiyal, R., Joshi, S. D., & Sen, E. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.03.017 · Cited by 28
Regulation of Cancer and Cancer-Related Genes via NAD +
Sharif, T., Martell, E., Dai, C., Ghassemi-Rad, M. S., Kennedy, B. E., Lee, P. W. K., & Gujar, S. A. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7478 · Cited by 25
CD38 downregulation modulates NAD+ and NADP(H) levels in thermogenic adipose tissues
Benzi, A., Sturla, L., Heine, M., Fischer, A. W., Spinelli, S., Magnone, M., Sociali, G., Parodi, A., Fenoglio, D., Emionite, L., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158819 · Cited by 25
An integrated in-silico Pharmaco-BioInformatics approaches to identify synergistic effects of COVID-19 to HIV patients
Hossain, M. A., Rahman, M. H., Sultana, H., Ahsan, A., Rayhan, S. I., Hasan, M. I., Sohel, M., Somadder, P. D., & Moni, M. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106656 · Cited by 27
Diabetes, diabetic complications, and flavonoids
Kulkarni, Y. A., Garud, M. S., Oza, M. J., Barve, K. H., & Gaikwad, A. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802972-5.00005-6 · Cited by 25
A High Dose of Isoniazid Disturbs Endobiotic Homeostasis in Mouse Liver
Li, F., Wang, P., Liu, K., Tarragó, M. G., Lu, J. L., Chini, E. N., & Ma, X. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070920 · Cited by 25
Self-citation
Nicotinamide and NAFLD: Is There Nothing New Under the Sun?
Guarino, M., & Dufour, J. (2019) · Metabolites · doi:10.3390/metabo9090180 · Cited by 25
Aryl hydrocarbon receptor (AHR) functions in infectious and sterile inflammation and NAD+-dependent metabolic adaptation
Bock, K. W. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03134-9 · Cited by 23
Clinical Insights on Caloric Restriction Mimetics for Mitigating Brain Aging and Related Neurodegeneration
Trisal, A., & Singh, A. K. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01493-2 · Cited by 29
NAD augmentation as a disease-modifying strategy for neurodegeneration
Dölle, C., & Tzoulis, C. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.03.013 · Cited by 25
Citrus medicaL. cv Diamante (Rutaceae) peel extract improves glycaemic status of Zucker diabetic fatty (ZDF) rats and protects against oxidative stress
Menichini, F., Tundis, R., Loizzo, M. R., Bonesi, M., d’Angelo, D., Lombardi, P., & Mastellone, V. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1115400 · Cited by 22
Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38+ macrophages and NAD+ decline
Ciaglia, E., Lopardo, V., Montella, F., Carrizzo, A., Pietro, P. D., Malavolta, M., Giacconi, R., Orlando, F., Cattaneo, M., Madeddu, P. R., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04535-z · Cited by 23
The use of a systems approach to increase NAD+ in human participants
Henderson, J. D., Quigley, S. N. Z., Chachra, S. S., Conlon, N. J., & Ford, D. (2024) · npj Aging · doi:10.1038/s41514-023-00134-0 · Cited by 22
NAD+ Degrading Enzymes, Evidence for Roles During Infection
Tan, A., & Doig, C. L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.697359 · Cited by 23
Towards Healthy Longevity: Comprehensive Insights from Molecular Targets and Biomarkers to Biological Clocks
Yusri, K., Kumar, S., Fong, S., Gruber, J., & Sorrentino, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126793 · Cited by 23
Comparative Analysis of Pharmacophore Features and Quantitative Structure–Activity Relationships for CD 38 Covalent and Non‐covalent Inhibitors
Zhang, S., Xue, X., Zhang, L., Zhang, L., & Liu, Z. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12606 · Cited by 21
The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research
Kitada, M., Araki, S., & Koya, D. (2023) · Cells · doi:10.3390/cells12040595 · Cited by 21
Nicotinamide Adenine Dinucleotide Supplementation to Alleviate Heart Failure: A Mitochondrial Dysfunction Perspective
Fan, Y., Zhao, H., Lu, L., & Wu, W. (2025) · Nutrients · doi:10.3390/nu17111855 · Cited by 21
New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy
Oberholtzer, N. P., Quinn, K. M., Chakraborty, P., & Mehrotra, S. (2022) · Cells · doi:10.3390/cells11040708 · Cited by 19
Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)
Bock, K. W. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113905 · Cited by 18
Apigenin relaxes rat intrarenal arteries, depresses Ca2+-activated Cl− currents and augments voltage-dependent K+ currents of the arterial smooth muscle cells
Jing, Y., Chen, R., Dong, M., Liu, Y., Hou, X., Guo, P., Li, W., Lv, J., & Zhang, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108926 · Cited by 18
SIRT1-dependent restoration of NAD+ homeostasis after increased extracellular NAD+ exposure
Buonvicino, D., Ranieri, G., Pittelli, M. G., Lapucci, A., Bragliola, S., & Chiarugi, A. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100855 · Cited by 17
Immunometabolic adaptation and immune plasticity in pregnancy and the bi-directional effects of obesity
Rees, A., Richards, O., Chambers, M., Jenkins, B., Cronin, J., & Thornton, C. A. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac003 · Cited by 22
Nurturing longevity through natural compounds: Where do we stand, and where do we go?
Todorova, M. N., Savova, M. S., Mihaylova, L. V., & Georgiev, M. I. (2024) · Food Frontiers · doi:10.1002/fft2.350 · Cited by 17
Discovery of a First-in-Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy
Li, Y., Liu, Y., Zhang, Y., Wu, Y., Xing, Z., Wang, J., & Fan, G.-H. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00391 · Cited by 16
Maternal body mass index is associated with an altered immunological profile at 28 weeks of gestation
Rees, A., Richards, O., Allen-Kormylo, A., Jones, N., & Thornton, C. A. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac023 · Cited by 16

Authors: Escande, C., Nin, V., Price, N. L., Capellini, V., Gomes, A. P., Barbosa, M. T., O’Neil, L., White, T. A., Sinclair, D. A., & Chini, E. N.
Affiliations: Mayo Clinic (US)
Department of Anesthesiology and Kogod Aging Center Mayo Clinic, Rochester, Minnesota
Harvard University (US)
Corresponding author: Chini, Eduardo N.
ORCID: Escande, Carlos
Price, Nathan L.
Capellini, Verena
Barbosa, Maria Thereza
White, Thomas A.
Sinclair, David A.
Chini, Eduardo N.
Venue: Diabetes
Publisher: American Diabetes Association
Published: 2013-03-14
Volume: 62
Issue: 4
Pages: 1084-1093
ISSN: 0012-1797 (ISSN-L)
1939-327X
DOI: 10.2337/db12-1139
PMC: PMC3609577
OpenAlex: W2112866277
Cited by: 332
References: 48
Citations by year: 2026: 27 · 2025: 20 · 2024: 30 · 2023: 17 · 2022: 37 · 2021: 38 · 2020: 33 · 2019: 23 · 2018: 31 · 2017: 25 · 2016: 17 · 2015: 18 · 2014: 11 · 2013: 5
FWCI: 5.35
Type: journal article
Language: en
Update notices: correction (2014-04-01)
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
creativecommons.org/licenses/by-nc-nd/3.0/ (vor, 3089 d)
Locations: Diabetes (publishedVersion, cc-by-nc-nd)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders: National Institute on Aging (R37AG028730, T32AG000222)
National Institute of Diabetes and Digestive and Kidney Diseases (P30DK050456, R01DK084055)
Topics: Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
Keywords: apigenin, CD38, NAD+ metabolism, sirtuins, protein acetylation, quercetin, metabolic syndrome, obesity, p53 acetylation, glucose homeostasis, lipid homeostasis, flavonoids, CD38 inhibitors
MeSH terms: Animals, Gene Expression Regulation, Humans, Mice, Inbred C57BL, NAD, Obesity, Quercetin, Random Allocation, Molecular Structure, Mice, Knockout, Metabolic Syndrome, Cell Line, Tumor, Apigenin, Mice, ADP-ribosyl Cyclase 1, Sirtuin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks